CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 58:43 AVI Clinical Trial Update (March 2012) 13 years ago Research & Clinical Trial Webinars,Webinars 1:08:47 ImagingDMD MRI Study (March 2012) 13 years ago Research & Clinical Trial Webinars,Webinars 1:00:21 Biglycan (December 2011) 13 years ago Research & Clinical Trial Webinars,Webinars 1:00:38 Fat Embolism Syndrome Following Mild Trauma in Duchenne (December 2011) 13 years ago Care Webinars,Webinars 59:50 Genetic Testing Webinar (November 2011) 13 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 1:01:55 Direct Access: Dr. Kathryn Wagner, Kennedy Krieger Institute (September 2011) 13 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars «1…232425Page 25 of 25
by: Parent Project Muscular Dystrophy
